Target $12.55 (was $11.60). With the risk of funding cuts easing the broker expects a volume recovery for FY12. There is also some scope for margin improvement.
To reflect this and a rolling forward of its model Credit Suisse has lifted its price target and upgraded to a Neutral rating.
Sector: Health Care Equipment & Services.
Target price is $12.55.Current Price is $12.21. Difference: $0.34 – (brackets indicate current price is over target). If SHL meets the Credit Suisse target it will return approximately 3% (excluding dividends, fees and charges – negative figures indicate an expected loss).